University of Pisa: Graves Ophthalmopathy trials
The registry lists 11 Graves Ophthalmopathy studies with University of Pisa as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 StudyNot yet recruitingNCT05049603Phase 3
- A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' OrbitopathyRecruitingNCT04776993Phase 3
- Sirolimus for Graves' Orbitopathy (GO)Not yet recruitingNCT04598815Phase 2
- A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' OrbitopathyNot yet recruitingNCT03098225Phase 4
- Sirolimus in Graves' OrbitopathyCompletedNCT05345119
- Genetics and Epigenetics of Graves' OrbitopathyCompletedNCT04488406
- Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' OrbitopathyCompletedNCT03498417
- T and B Cells in Graves' OrbitopathyCompletedNCT03195296
- Effects of Atorvastatin in Graves' Orbitopathy (GO)CompletedNCT03110848Phase 2
- Disappearance of Graves' OrbitopathyCompletedNCT03103607
- Graves' Orbitopathy and HypercholesterolemiaCompletedNCT02721992